Plantar Fasciitis Treatment Market by Drug Class (Corticosteroids, Nonsteroidal Anti-Inflammatory Drugs, Others), Disease Type (Acute Plantar Fasciitis, Chronic Plantar Fasciitis, Others), End User (Hospital & Clinics, Ambulatory Surgical Centers, Others) and Forecast 2026-2034
$3,000.00
Report Specifications
The plantar fasciitis treatment market is expanding as the prevalence of this debilitating foot condition continues to rise among active adults and the elderly. Plantar fasciitis, characterized by inflammation of the tissue connecting the heel bone to the toes, is a leading cause of heel pain.
The market encompasses a range of conservative and interventional treatments, including orthotic devices, night splints, physical therapy, shockwave therapy, and pharmacological injections. The increasing adoption of non-invasive and minimally invasive procedures is a key trend, as patients seek rapid pain relief and restoration of mobility without the downtime associated with surgery.
The global plantar fasciitis treatment market research report provides market size ($million 2024 to 2034), market share analysis, growth trends and forecast (CAGR%, 2026 to 2034).
The global plantar fasciitis treatment market segmented by drug class (corticosteroids, nonsteroidal anti-inflammatory drugs, others), disease type (acute plantar fasciitis, chronic plantar fasciitis, others), end user (hospital & clinics, ambulatory surgical centers, others), and geography.
The global plantar fasciitis treatment market research report is further segmented by geography into North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), Latin America (Brazil, Mexico, Rest of LA), and Rest of the World.
In addition, the global plantar fasciitis treatment market report provides detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis, and market profitability analysis by key products and regions or countries. The report also tracks the major competitors operating in the global market through company overview, financial snapshots, major products, technologies, services offered and recent developments.
Major players operating in the global plantar fasciitis treatment market and profiled in this report include AbbVie, Inc., Bayer AG, GSK plc, Johnson & Johnson, Novartis AG, Pfizer, Inc., Sanofi S.A., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Viatris, Inc.
DATA INCLUDED: Plantar Fasciitis Treatment Market Size, Plantar Fasciitis Treatment Market Share, Plantar Fasciitis Treatment Market Growth Rates, Plantar Fasciitis Treatment Market Trends, and Plantar Fasciitis Treatment Market Forecast to 2034
Market Data:
- Base Year Estimation: 2025
- Historical Data Range: 2024-2025
- Forecast Period: 2026-2034
- Market Representation: Revenue in $million and CAGR % from 2026 to 2034
- Regional Scope: North America, Europe, Asia Pacific, Latin America, Rest of the World (Middle East & Africa)
- Country Scope: U.S., Canada, U.K., Germany, France, Italy, Spain, Japan, China, India, South Korea, Brazil, Mexico, South Africa, South Korea, Saudi Arabia, UAE, and other countries.
- Report Coverage: Revenue forecasts, company market share, competitive landscape analysis, growth factors, and market trends
- Customization Scope (15% Free): Accommodation of specific or custom requirements beyond the current report scope.
Qualitative Analysis:
- Industry Overview
- Industry Trends
- Market Driver, Restraints, and Opportunities
- Market Size
- Growth Trends
- Market Profitability Analysis
- Market Attractiveness Matrix
- Competitive Landscape
- Company Overview
- Financial Performance
- Product Portfolio
- Strategic Insights
- Recent Developments
Quantitative Analysis:
- Market Size Projections: Comprehensive estimates and forecasts for all segments
- Regional Market Analysis: Estimates and forecasts for key countries
- Corporate Financial Performance: Analysis of company financials
- Competitive Landscape: Market share analysis of leading companies
For inquiries regarding discounts on single or bundled report purchases, please reach out to us.
- Introduction
- Executive Summary
- Market Size Estimation ($million, 2024-2034)
- Forecast Estimation ($million and CAGR%, 2026-2034)
- Research Methodology
- Market Landscape
- Market Dynamics
- Drivers
- Barriers
- Opportunities
- Market Share Analysis
- Companies
- Drugs
- Market Trends Analysis
- Key success factors
- Market Growth Rate
- Market Attractiveness Analysis
- Market Profitability Analysis
- Buyer power
- Supplier power
- Barriers to entry
- Threat of substitute products
- Rivalry among firms in the industry
- Distribution Channels
- Market Dynamics
- Market Segmentation [refer Market Segments and Companies Tab]
- Drug Class or Drug (Brand) Type
- Drug or Disorder Test
- Indication Type
- Drug Treatment
- Mechanism of Action
- Therapeutic Area or Nature of Application
- End User Groups
- Geography (Region, Country)
- North America (U.S., Canada)
- Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
- Asia Pacific (Japan, China, India, Rest of APAC)
- Latin America (Brazil, Mexico, Rest of LA)
- Rest of the World (Middle East & Africa)
- Regulatory Overview
- IND, NDA filed, FDA, EMEA Approvals
- Pipeline Analysis (Phase 1, 2 and 3 Drugs)
- Phase 3 Drugs Forecast Estimation (Approval to 2033)
- Phase 1 and 2 Drugs – Qualitative Analysis
- Company Profiles [refer Market Segments and Companies Tab]
- Company Overview
- Financial Snapshot
- Product Portfolio
- Business Strategies
- Recent Developments
- Recommendations
- References
Key Questions Answered:
1. What are the factors driving and limiting this market, key success factors and challenges?
2. Which are the leading competitors in the market, their market share, profitability and key trends by product, technology, services portfolio?
3. How do markets perform between countries and regions?
4. What market segments are contributing to maximum share and greatest growth?
5. What is the product or procedure volumes by country and regions?
Actionable Insights Included:
1. Product portfolio matrix (Share vs. Growth)
2. Market attractiveness (Region vs. Growth)
3. Spot matrix (Product vs. Region)
4. Geographic distribution matrix (Share vs. Growth)
Plantar Fasciitis Treatment Market
1. Drug Class
1.1. Corticosteroids
1.2. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
1.3. Others
2. Disease Type
2.1. Acute Plantar Fasciitis
2.2. Chronic Plantar Fasciitis
2.3. Others
3. End User
3.1. Hospital & Clinics
3.2. Ambulatory Surgical Centers (ASCs)
3.3. Others
4. Geography
4.1. North America (U.S., Canada)
4.2. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
4.3. Asia Pacific (Japan, China, India, Rest of APAC)
4.4. Latin America (Brazil, Mexico, Rest of LA)
4.5. Rest of the World
5. Company Profiles
5.1. AbbVie, Inc.
5.2. Bayer AG
5.3. GSK plc
5.4. Johnson & Johnson
5.5. Novartis AG
5.6. Pfizer, Inc.
5.7. Sanofi S.A.
5.8. Sun Pharmaceutical Industries Ltd.
5.9. Teva Pharmaceutical Industries Ltd.
5.10. Viatris, Inc.
Related Reports
-

Active Pharmaceutical Ingredients Market and Forecast 2026-2034
$3,000.00 -

Breast Cancer Therapeutics Market and Forecast 2026-2034
$3,000.00 -

Dyslipidemia Drugs Market and Forecast 2026-2034
$3,000.00 -

Erectile Dysfunction Market and Forecast 2026-2034
$3,000.00 -

Kidney Cancer Drugs Market and Forecast 2026-2034
$3,000.00 -

Dilated Cardiomyopathy Therapeutics Market and Forecast 2026-2034
$3,000.00 -

Diabetes Drugs and Devices Market and Forecast 2026-2034
$3,000.00 -

Hospital-Acquired Pneumonia Drugs Market and Forecast 2026-2034
$3,000.00